Total | GOLD classification | FEV1/height2 classification L·m−2 | |||||||
I | II | III | IV | >0.5 | ≤0.5 to >0.4 | ≤0.4 to >0.3 | ≤0.3 | ||
Subjects n | 24 | 5 | 9 | 6 | 4 | 14 | 4 | 3 | 3 |
FEV1 z-score | |||||||||
Baseline | −3.18 | −0.55 | −2.48 | −4.52 | −6.05 | −1.82 | −4.18 | −5.22 | −6.19 |
After 5 years | −3.56* | −0.96 | −3.25* | −4.54 | −6.03 | −2.38* | −4.25 | −5.45 | −6.26 |
Change per year | −0.08 | −0.08 | −0.15 | −0.05 | 0.004 | −0.11 | −0.01 | −0.05 | −0.02 |
X5 z-score | |||||||||
Baseline | −1.06 | −0.33 | −0.45 | −1.62 | −2.48 | −0.41 | −1.55 | −1.95 | −2.50 |
After 5 years | −1.53* | −0.51 | −1.28* | −2.08 | −2.54 | −1.01* | −1.91 | −2.37 | −2.59 |
Change per year | −0.09 | −0.05 | −0.16 | −0.09 | −0.01 | −0.12 | −0.07 | −0.08 | −0.02 |
Fres z-score | |||||||||
Baseline | 1.18 | 0.45 | 0.42 | 1.81 | 2.87 | 0.45 | 1.52 | 2.41 | 2.94 |
After 5 years | 1.89* | 0.80 | 1.45* | 2.56 | 3.23 | 1.25* | 2.12 | 3.05 | 3.42 |
Change per year | 0.14 | 0.07 | 0.21 | 0.15 | 0.07 | 0.16 | 0.12 | 0.13 | 0.10 |
AX z-score | |||||||||
Baseline | 1.00 | 0.37 | 0.40 | 1.53 | 2.34 | 0.40 | 1.35 | 1.95 | 2.40 |
After 5 years | 1.50* | 0.59 | 1.17 | 2.01 | 2.60 | 1.00* | 1.73 | 2.30 | 2.75 |
Change per year | 0.10 | 0.04 | 0.16 | 0.10 | 0.05 | 0.12 | 0.08 | 0.07 | 0.07 |
Data are presented as mean, unless otherwise stated. GOLD: Global Initiative for Chronic Obstructive Lung Disease; X5: Xrs at 5 Hz; Fres: resonant frequency; AX: low-frequency reactance area. *: p<0.05 versus baseline.